Company Filing History:
Years Active: 2021-2024
Title: Kexing Wang: Innovator in Pharmaceutical Composition
Introduction
Kexing Wang is a notable inventor based in Chengdu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of albumin-based compositions. With a total of two patents to his name, Wang's work focuses on enhancing the safety and efficacy of medical treatments.
Latest Patents
Wang's latest patents include an innovative albumin pharmaceutical composition and its preparation method. This composition comprises albumin and at least one amino acid with a relative molecular mass of 145-175. Clinically, this formulation is designed to effectively reduce undesirable responses, such as rash, urticaria, anaphylaxis, and potential immune responses in the human body caused by albumin polymers and dimers. This advancement further ensures safety in clinical medication.
Career Highlights
Kexing Wang is associated with the Sichuan Kelun Pharmaceutical Research Institute Co. Ltd., where he continues to push the boundaries of pharmaceutical research. His work is instrumental in developing safer medical treatments that can significantly improve patient outcomes.
Collaborations
Wang collaborates with esteemed colleagues, including Zhengxing Su and Likai Yang, who contribute to his research endeavors. Their combined expertise enhances the innovative potential of their projects.
Conclusion
Kexing Wang's contributions to pharmaceutical innovations, particularly in albumin compositions, highlight his commitment to improving clinical safety and efficacy. His work is paving the way for advancements in medical treatments that prioritize patient well-being.